Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The charts of patients who developed pulmonary embolism in the course of COVID-19 will be evaluated, retrospectively. Clinical features and laboratory data will be analyzed.
Patients with COVID-19 infection will be evaluated retrospectively. Demographic data, clinical and laboratory findings will be recorded. Findings of patients with pulmonary embolism and withour pulmonary embolism will be compared.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Covid-19 Patients with Pulmonary embolism | Clinically demonstared cases infected with COVID-19 who developed pulmonary embolism. |
| |
| Covid-19 Patients without Pulmonary embolism | Clinically demonstared cases infected with COVID-19 who did not develop pulmonary embolism. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| intensive care unit admission ratio | Other | intensive care unit admission ratio |
|
| Measure | Description | Time Frame |
|---|---|---|
| pulmonary embolism | development of pulmonary embolism | 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Intensive care unit | need for admission to intensive care unit | 1 year |
| mortality | mortality rate due to pulmonary embolism | 1 year |
Not provided
Inclusion Criteria:
- All patients with positive RT-PCR for COVID-19
Exclusion Criteria:
- All patients with negative RT-PCR for COVID-19
Not provided
Not provided
Not provided
All COVID-19 patients with positive RT-PCR tests will be analyzed retrospectively. Patients with and without pulmonary embolism will be compared in terms of age, gender, side disease, hospitalization in intensive care, mortality rates etc.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Cevdet Duran, M.D. | Contact | +905334298585 | drcduran@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Cevdet Duran, M.D. | Uşak University Medical School | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Uşak University | Recruiting | Uşak | 64200 | Turkey (Türkiye) |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| D011655 | Pulmonary Embolism |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
| D014777 |
| Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |
| D004617 | Embolism |
| D016769 | Embolism and Thrombosis |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |